Status:
TERMINATED
Continuous Wireless Monitoring of Vital Signs and Automated Alerts of Patient Deterioration in Patients Admitted With COVID-19 Infection
Lead Sponsor:
University Hospital Bispebjerg and Frederiksberg
Collaborating Sponsors:
Rigshospitalet, Denmark
Conditions:
Clinical Deterioration
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
For patients admitted with COVID-19 infection, it is often difficult to predict if or when their clinical condition will deteriorate. However subtle changes in vital signs are usually present 8 to 24 ...
Eligibility Criteria
Inclusion
- Inclusion criteria
- Adult patients (≥18 years).
- Inclusion possible within 72 hours of admission, OR within 48 hours of discharge from an ICU to a medical ward
- At least one expected overnight stay.
- Patient admitted with confirmed COVID-19 infection
- Exclusion criteria
- Patient expected not to cooperate with study procedures.
- Allergy to plaster or silicone.
- Patients admitted for palliative care only (i.e. no active treatment).
- Patients previously enrolled in the studies WARD-COPD (H-18026653) or WARD-Surgery (H-17033535).
- Inability to give informed consent.
Exclusion
Key Trial Info
Start Date :
November 3 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
97 Patients enrolled
Trial Details
Trial ID
NCT04724681
Start Date
November 3 2020
End Date
December 31 2022
Last Update
June 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bispebjerg and Frederiksberg Hospital
Copenhagen, Denmark, 2400